{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:35:47Z","timestamp":1777725347030,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 DK056338"],"award-info":[{"award-number":["P30 DK056338"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10620-022-07587-5","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T09:02:44Z","timestamp":1654938164000},"page":"761-769","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6113-4780","authenticated-orcid":false,"given":"Mimi C.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niharika","family":"Mallepally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed O.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashem B.","family":"El-Serag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron P.","family":"Thrift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"key":"7587_CR1","doi-asserted-by":"crossref","unstructured":"Wang Z, El-Serag HB, Thrift AP. Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA. Dig Dis Sci 2020.","DOI":"10.1007\/s10620-020-06397-x"},{"key":"7587_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jnci\/djx262","volume":"110","author":"WF Anderson","year":"2018","unstructured":"Anderson WF, Rabkin CS, Turner N et al. The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites. J Natl Cancer Inst 2018;110:608\u2013615.","journal-title":"J Natl Cancer Inst"},{"key":"7587_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol 2020;18:534\u2013542.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7587_CR4","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969\u20132017) <Katrina\/Rita Population Adjustment>, National Cancer Institute, DCCPS, Surveillance Research Program, released December 2019. Underlying mortality data provided by NCHS (www.cdc.gov\/nchs)."},{"key":"7587_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2019.12.003","volume":"158","author":"S Gupta","year":"2020","unstructured":"Gupta S, Li D, El Serag HB et al. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology 2020;158:693\u2013702.","journal-title":"Gastroenterology"},{"key":"7587_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"P Pimentel-Nunes","year":"2019","unstructured":"Pimentel-Nunes P, Lib\u00e2nio D, Marcos-Pinto R et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019;51:365\u2013388.","journal-title":"Endoscopy"},{"key":"7587_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/ajg.2009.728","volume":"105","author":"P Correa","year":"2010","unstructured":"Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010;105:493\u2013498.","journal-title":"Am J Gastroenterol"},{"key":"7587_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.14309\/ajg.0000000000000498","volume":"115","author":"MC Tan","year":"2020","unstructured":"Tan MC, Mallepally N, Liu Y et al. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol 2020;115:381\u2013387.","journal-title":"Am J Gastroenterol"},{"key":"7587_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1053\/j.gastro.2018.05.026","volume":"155","author":"M Saumoy","year":"2018","unstructured":"Saumoy M, Schneider Y, Shen N et al. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648\u2013660.","journal-title":"Gastroenterology"},{"key":"7587_CR10","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.cgh.2020.10.041","volume":"19","author":"MC Tan","year":"2021","unstructured":"Tan MC, Graham DY. Screening for Gastric Cancer: Focus on the Ants Instead of the Ant Hill. Clin Gastroenterol Hepatol 2021;19:1990\u20131991.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7587_CR11","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s10620-014-3275-3","volume":"59","author":"FH Lui","year":"2014","unstructured":"Lui FH, Tuan B, Swenson SL et al. Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992\u20132009 SEER data. Dig Dis Sci 2014;59:3027\u20133034.","journal-title":"Dig Dis Sci"},{"key":"7587_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/annonc\/mdr135","volume":"23","author":"I Tramacere","year":"2012","unstructured":"Tramacere I, Negri E, Pelucchi C et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012;23:28\u201336.","journal-title":"Ann Oncol"},{"key":"7587_CR13","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/cam4.680","volume":"5","author":"KK S\u00f8gaard","year":"2016","unstructured":"S\u00f8gaard KK, Farkas DK, Pedersen L et al. Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers. Cancer Med 2016;5:1341\u20131351.","journal-title":"Cancer Med"},{"key":"7587_CR14","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1097\/MCG.0b013e3181a159c4","volume":"44","author":"CM Shin","year":"2010","unstructured":"Shin CM, Kim N, Yang HJ et al. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol 2010;44:e34\u2013e39.","journal-title":"J Clin Gastroenterol"},{"key":"7587_CR15","unstructured":"IARC Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No. 8), 2014."},{"key":"7587_CR16","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.3748\/wjg.v20.i38.13842","volume":"20","author":"V Pasechnikov","year":"2014","unstructured":"Pasechnikov V, Chukov S, Fedorov E et al. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol 2014;20:13842\u201313862.","journal-title":"World J Gastroenterol"},{"key":"7587_CR17","doi-asserted-by":"crossref","unstructured":"El-Serag HB, Kao JY, Kanwal F, et al. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol 2018 Jul;16:992\u20131002.","DOI":"10.1016\/j.cgh.2018.03.013"},{"key":"7587_CR18","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10620-019-05955-2","volume":"65","author":"TH Nguyen","year":"2020","unstructured":"Nguyen TH, Mallepally N, Hammad T et al. Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population. Dig Dis Sci 2020;65:2403\u20132411.","journal-title":"Dig Dis Sci"},{"key":"7587_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gie.2016.02.028","volume":"84","author":"GH Kim","year":"2016","unstructured":"Kim GH, Liang PS, Bang SJ et al. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc 2016;84:18\u201328.","journal-title":"Gastrointest Endosc"},{"key":"7587_CR20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1053\/j.gastro.2017.01.029","volume":"152","author":"JK Jun","year":"2017","unstructured":"Jun JK, Choi KS, Lee HY et al. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology 2017;152:1319-1328.e7.","journal-title":"Gastroenterology"},{"key":"7587_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jjco\/hyy077","volume":"48","author":"C Hamashima","year":"2018","unstructured":"Hamashima C. Update version of the Japanese Guidelines for Gastric Cancer Screening. Jpn J Clin Oncol 2018;48:673\u2013683.","journal-title":"Jpn J Clin Oncol"},{"key":"7587_CR22","doi-asserted-by":"publisher","first-page":"E709","DOI":"10.1055\/s-0042-106959","volume":"4","author":"CP Selinger","year":"2016","unstructured":"Selinger CP, Cochrane R, Thanaraj S et al. Gastric ulcers: malignancy yield and risk stratification for follow-up endoscopy. Endosc Int Open 2016;4:E709\u2013E714.","journal-title":"Endosc Int Open"},{"key":"7587_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/gut.50.3.378","volume":"50","author":"JL Whiting","year":"2002","unstructured":"Whiting JL, Sigurdsson A, Rowlands DC et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378\u2013381.","journal-title":"Gut"},{"key":"7587_CR24","doi-asserted-by":"crossref","unstructured":"den Hollander WJ, Holster IL, den Hoed CM, et al. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut 2018.","DOI":"10.1136\/gutjnl-2017-314498"},{"key":"7587_CR25","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/00952990.2018.1456545","volume":"44","author":"JC Higgins-Biddle","year":"2018","unstructured":"Higgins-Biddle JC, Babor TF. A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions. Am J Drug Alcohol Abuse 2018;44:578\u2013586.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"7587_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-018-0501-2","volume":"18","author":"AC Melzer","year":"2018","unstructured":"Melzer AC, Pinsker EA, Clothier B et al. Validating the use of veterans affairs tobacco health factors for assessing change in smoking status: accuracy, availability, and approach. BMC Med Res Methodol 2018;18:39.","journal-title":"BMC Med Res Methodol"},{"key":"7587_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa1909666","volume":"382","author":"IJ Choi","year":"2020","unstructured":"Choi IJ, Kim CG, Lee JY et al. Family History of Gastric Cancer and Helicobacter pylori Treatment. N Engl J Med 2020;382:427\u2013436.","journal-title":"N Engl J Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07587-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T05:12:35Z","timestamp":1678684355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07587-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["7587"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07587-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mohamed O. Othman is consultant for Olympus, Boston Scientific Corporation, Conmed, Apollo, Lumendi and Abbvie. Mohamed O. Othman had received research grants from Abbvie, Lumendi and Lucid Diagnostics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board (IRB) of Baylor College of Medicine approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Given the retrospective nature of this study, all data was collected for clinical purposes and informed consent was not obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}